# Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins

> **NCT05062239** · NA · RECRUITING · sponsor: **Lars Peter Riber** · enrollment: 100 (estimated)

## Conditions studied

- Postoperative Atrial Fibrillation

## Interventions

- **DRUG:** Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
- **DRUG:** No-intervention.

## Key facts

- **NCT ID:** NCT05062239
- **Lead sponsor:** Lars Peter Riber
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062239, "Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT05062239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*